Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05665998
Other study ID # UP2
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 22, 2023
Est. completion date July 2025

Study information

Verified date May 2023
Source Ecole Polytechnique Fédérale de Lausanne
Contact Jocelyne Bloch, MD
Phone +41 79 556 29 51
Email jocelyne.bloch@chuv.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cervical spinal cord stimulation can elicit arm and hand movements through recruitment of proprioceptive neurons in the dorsal roots. In participants with cervical spinal cord injury, the spare roots bellow the lesion can be used to reactivate motor function. Decoding of motor intentions can be achieved through implantable electrocorticography (ECoG) devices. In this study, the investigators will use an investigational system using ECoG signal recording over the motor cortex to drive muscle specific electrical epidural spinal cord stimulation (EES). The investigators will assess the safety and preliminary efficacy of this system in 3 participants.


Description:

In a current first-in-human clinical trial, called STIMO, Electrical Epidural Spinal Stimulation (EES) is applied to enable individuals with chronic severe spinal cord injury (SCI) to complete intensive locomotor neurorehabilitation training. In this clinical feasibility study, EES triggered an immediate enhancement of walking function, and was integrated in an intensive neurorehabilitation program. This therapy improved leg motor control and triggered neurological recovery in individuals with severe SCI to a certain extent (Wagner et al. 2018, Kathe et al. 2022). Concurrently, preclinical and clinical evidence demonstrated a similar recruitment of upper limb muscles through cervical spinal cord stimulation, re-triggering arm movements after paralysis. The spatial and temporal modulation of the electrical stimulation can selectively activate muscle groups towards a specific function. Clinatec (CEA, Grenoble, France) has developed an implantable electrocorticogram (ECoG) recording device with a 64-channel epidural electrode array capable of recording electrical signals from the motor cortex for an extended period and with a high signal to noise ratio. This ECoG-based system allowed tetraplegic patients to control an exoskeleton (Clinicaltrials.gov, NCT 02550522) with up to 8 degrees of freedom for the upper limb control (Benabid et al., 2019). This device has been implanted in 4 individuals so far; one of them has been using this system both at the hospital and at home for more than 3 years. Another ongoing clinical study: STIMO-BSI (Brain Spine Interface) (Clinicaltrials.gov: NTC04632290), is combining the EES and ECoG technology to allow leg motor control in patients with chronic SCI through the decoding of cortical signals. In this study, the investigators will test the safety and preliminary efficacy of ECoG-controlled EES in individuals with cervical SCI and establish a direct bridge between the participants' motor intention and the spinal cord below the lesion, which could restore voluntary control of arm movements as well as promote neurological recovery when combined with neurorehabilitation.


Recruitment information / eligibility

Status Recruiting
Enrollment 3
Est. completion date July 2025
Est. primary completion date March 31, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility - Must provide Informed Consent as documented by signature (Appendix Informed Consent Form), - Must be at least 18 years old and no older than 75 years old at the time of enrolment, - Must be suffering from non-progressive traumatic cervical spinal cord injury, - Must be graded A, B, C, or D in the American Spinal Injury Association (ASIA) Impairment Scale (AIS) classification, - Must have completed primary standard of care rehabilitation, - Must be severely impaired in his upper limb function as determined by the investigator, - Must have sustained the injury at least 6 months before signing the consent form, - Must be able to understand and interact with the study team in French or English, - Must agree to comply in good faith with all conditions of the study and to attend all scheduled appointments, - Must use safe contraception for women of childbearing capacity, - Must not be pregnant nor breast feeding, - Must not have history of severe autonomic dysreflexia, - Must not have brain damage, - Must not have history of epilepsy, - Must not have spinal stenosis, - Must not have gastrointestinal ulcers in the last five years, - Must not have any psychological disorder, - Must not have the intention to become pregnant during the course of the study, - Must not be known or suspected of drug or alcohol abuse, - Must not have participated in another clinical study using drugs or medical devices within the 30 days preceding and during the present study, - Must not have previously been injected with stem cells in the spinal cord, - Must not be the investigator himself, his/her family members, employees or other dependent persons, - Must not have any unstable or significant medical condition that is likely to interfere with study procedures or likely to confound study endpoint evaluations as determined by the Investigator, - Must not have any hematological disorders with increased risk for surgical intervention, - Must not require ventilator support, - Must not suffer from spinal cord injury from other etiology than traumatic (ischemic, tumoral, autoimmune, etc), - Must not be subject to spasms that limit the ability of the subject to participate in the study training as determined by the investigator, - Must not display spinal stenosis or post traumatic damage at location of implantation, - Must not require the use of an intrathecal baclofen pump, - Must not be implanted with a device such as pacemakers or defibrillators, - Must not have any indication that would require an MRI, - Must not suffer from congenital nor acquired upper limb abnormalities (affection of joints or bones).

Study Design


Intervention

Device:
ARC-BSI Cervical system
Unilateral implantation of a 64 channel - ECoG array over the sensory motor cortex combined with an implantation of 32 channel spinal cord stimulation system over the cervical region. The system decodes the motor attempts of the participant and translates those intentions into modulation of electrical stimulation.

Locations

Country Name City State
Switzerland CHUV Lausanne Vaud

Sponsors (1)

Lead Sponsor Collaborator
Ecole Polytechnique Fédérale de Lausanne

Country where clinical trial is conducted

Switzerland, 

References & Publications (6)

Benabid AL, Costecalde T, Eliseyev A, Charvet G, Verney A, Karakas S, Foerster M, Lambert A, Moriniere B, Abroug N, Schaeffer MC, Moly A, Sauter-Starace F, Ratel D, Moro C, Torres-Martinez N, Langar L, Oddoux M, Polosan M, Pezzani S, Auboiroux V, Aksenova T, Mestais C, Chabardes S. An exoskeleton controlled by an epidural wireless brain-machine interface in a tetraplegic patient: a proof-of-concept demonstration. Lancet Neurol. 2019 Dec;18(12):1112-1122. doi: 10.1016/S1474-4422(19)30321-7. Epub 2019 Oct 3. — View Citation

Kathe C, Skinnider MA, Hutson TH, Regazzi N, Gautier M, Demesmaeker R, Komi S, Ceto S, James ND, Cho N, Baud L, Galan K, Matson KJE, Rowald A, Kim K, Wang R, Minassian K, Prior JO, Asboth L, Barraud Q, Lacour SP, Levine AJ, Wagner F, Bloch J, Squair JW, Courtine G. The neurons that restore walking after paralysis. Nature. 2022 Nov;611(7936):540-547. doi: 10.1038/s41586-022-05385-7. Epub 2022 Nov 9. — View Citation

Larzabal C, Bonnet S, Costecalde T, Auboiroux V, Charvet G, Chabardes S, Aksenova T, Sauter-Starace F. Long-term stability of the chronic epidural wireless recorder WIMAGINE in tetraplegic patients. J Neural Eng. 2021 Sep 9;18(5). doi: 10.1088/1741-2552/ac2003. — View Citation

Lorach H, Charvet G, Bloch J, Courtine G. Brain-spine interfaces to reverse paralysis. Natl Sci Rev. 2022 Jan 18;9(10):nwac009. doi: 10.1093/nsr/nwac009. eCollection 2022 Oct. No abstract available. — View Citation

Rowald A, Komi S, Demesmaeker R, Baaklini E, Hernandez-Charpak SD, Paoles E, Montanaro H, Cassara A, Becce F, Lloyd B, Newton T, Ravier J, Kinany N, D'Ercole M, Paley A, Hankov N, Varescon C, McCracken L, Vat M, Caban M, Watrin A, Jacquet C, Bole-Feysot L, Harte C, Lorach H, Galvez A, Tschopp M, Herrmann N, Wacker M, Geernaert L, Fodor I, Radevich V, Van Den Keybus K, Eberle G, Pralong E, Roulet M, Ledoux JB, Fornari E, Mandija S, Mattera L, Martuzzi R, Nazarian B, Benkler S, Callegari S, Greiner N, Fuhrer B, Froeling M, Buse N, Denison T, Buschman R, Wende C, Ganty D, Bakker J, Delattre V, Lambert H, Minassian K, van den Berg CAT, Kavounoudias A, Micera S, Van De Ville D, Barraud Q, Kurt E, Kuster N, Neufeld E, Capogrosso M, Asboth L, Wagner FB, Bloch J, Courtine G. Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis. Nat Med. 2022 Feb;28(2):260-271. doi: 10.1038/s41591-021-01663-5. Epub 2022 Feb 7. — View Citation

Wagner FB, Mignardot JB, Le Goff-Mignardot CG, Demesmaeker R, Komi S, Capogrosso M, Rowald A, Seanez I, Caban M, Pirondini E, Vat M, McCracken LA, Heimgartner R, Fodor I, Watrin A, Seguin P, Paoles E, Van Den Keybus K, Eberle G, Schurch B, Pralong E, Becce F, Prior J, Buse N, Buschman R, Neufeld E, Kuster N, Carda S, von Zitzewitz J, Delattre V, Denison T, Lambert H, Minassian K, Bloch J, Courtine G. Targeted neurotechnology restores walking in humans with spinal cord injury. Nature. 2018 Nov;563(7729):65-71. doi: 10.1038/s41586-018-0649-2. Epub 2018 Oct 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of treatment-related serious adverse events (SAEs). Through completion of the study 12 months
Secondary Graded and Redefined Assessment of Strength Sensibility, and Prehension (GRASSP) score 0-232 points, higher score indicating better performance 7 months
Secondary Action Research Arm Test (ARAT) score 0-57 points, higher score indicating better performance 7 months
Secondary Capabilities of the Upper Extremity Test (CUE-T) 0-68 points, higher score indicating better performance 7 months
Secondary Range of Motion (in rad) 7 months
Secondary Grasp force (in N) 7 months
Secondary Pinch force (in N) 7 months
Secondary International Standards for Neurological Classification of SCI (ISNCSCI) score 0-324 points, higher score indicating better function 7 months
Secondary Maximum voluntary contraction (in N.m) 7 months
Secondary Somato-sensory evoked potential amplitude (in mV) 7 months
See also
  Status Clinical Trial Phase
Recruiting NCT04736849 - Epidural and Dorsal Root Stimulation in Humans With Spinal Cord Injury N/A
Not yet recruiting NCT06437548 - Epidural Stimulation for Upper Extremity Function N/A
Terminated NCT03513783 - Elbow Extension Restoration Surgery in People With Tetraplegia: Evolution of the Muscular Co-activations of the Upper Limb During the Post-operative Rehabilitation N/A
Recruiting NCT05432999 - Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury N/A
Completed NCT03698136 - Electrical Stimulation in Denervated Muscles of the Upper Limbs N/A
Recruiting NCT05553457 - MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury N/A
Completed NCT04020770 - Influence of Upper Extremity Vibration on Spasticity and Function in Persons With Tetraplegia N/A
Completed NCT04964635 - TETRAGRIP II - Usability Trial of an FES Orthosis for People With Tetraplegia. N/A
Recruiting NCT06094205 - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02) N/A
Enrolling by invitation NCT02602639 - Functional Electrical Stimulation With Rowing as Exercise After Spinal Cord Injury N/A
Completed NCT01467856 - Sleep Disordered Breathing N/A
Completed NCT00385918 - Robotically Assisted Treadmill Training in Spinal Cord Injury (SCI) N/A
Recruiting NCT05724173 - Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia N/A
Completed NCT05555914 - Neural Stimulation for Hand Grasp in People With Tetraplegia N/A
Completed NCT03975075 - Biofeedback Treatment of Anxiety Associated With Chronic Spinal Cord Injury N/A
Recruiting NCT01474148 - A Neuroprosthesis for Seated Posture and Balance N/A
Active, not recruiting NCT03811301 - [BrainConnexion] - Neurodevice Phase I Trial N/A
Terminated NCT01498991 - Spinal Cord Injury Leg Rehabilitation Phase 1/Phase 2
Completed NCT03237091 - Enhancing Corticospinal Excitability to Improve Functional Recovery N/A
Completed NCT01393444 - ECoG Direct Brain Interface for Individuals With Upper Limb Paralysis N/A